Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Intellectual Disability × Population Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 2 Neoplasms 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Lymphoma, Follicular 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Intellectual Disability 1 Heart Failure 1 Gynecologic Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Blood Loss, Surgical 1 Arrhythmias, Cardiac 1

Interventions

Population Groups 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05167929 2022-03-09

Self-determination Enhancement Group for Adults With Mild Intellectual Disability and Their Caregivers in Hong Kong

Chinese University of Hong Kong

Phase NA Unknown

Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡